Recombinant Mouse Anti-MAGEA5 Soluble TCR (A31C2-B32B5) (KIH) (CAT#: VS-0622-YF5905)
Mouse TCR (A31C2-B32B5) recognizes MAGEA5 peptide (KVAELVHFL) in the context of HLA-A*0201. Soluble TCR is expressed with Knob-in-hole (KIH) strategy (scTCR-hIgG Knob, scTCR-hIgG Hole). Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Mouse
- Target
- MAGEA5
- Species Reactivity
- Human
- Epitope
- KVAELVHFL
- MHC
- HLA-A*0201
- Clone
- A31C2-B32B5
- Type
- Soluble TCR (KIH)
- Related Disease
- Melanoma
- TCR Expression Strategy
- KIH strategy: scTCR-human IgG Knob and scTCR-human IgG Hole can form heterodimer based on Knob-in-hole (KIH) strategy. The soluble TCR contains single chain TCR. With this KIH antibody production strategy, VL/VH will be replaced with Valpha-linker-Vbeta (single chain TCR).
Target
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone A31C2-B32B5"
See other products for "MAGEA5"
Select a product category from the dropdown menu below to view related products.
Please select product type
MHC Tetramer Products for Cancer
CAT | Product Name | Application | Type |
---|---|---|---|
MHC-LC214 | PE-H-2Kb/Human MAGE-A5 (HNTQYCNL) MHC Tetramer | FCM | |
MHC-LC215 | APC-H-2Kb/Human MAGE-A5 (HNTQYCNL) MHC Tetramer | FCM |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF5905. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, IF, IP, Neut, FuncS, ELISA, FC
Application: Neut, ELISA, IF, IP, FuncS, FC, ICC
Application: ELISA, Neut, IF, IP, FC, FuncS
Application: Inhib, Cyt
Application: ELISA, IP, WB, IHC, IF, FuncS
Application: ELISA, WB
Application: ELISA, FC, WB, Inhib, IHC
Application: ELISA, Block, WB, FC, IP
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.